SCHEMBL540861

SCHEMBL540861

O=C1C(O)=CCN1CCc1c[nH]c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
MAPT P10636 5/20 0.56
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
NPC1 O15118 2/20 0.56
GAA P10253 2/20 0.56
HPGD P15428 1/20 0.54
HTR2A P28223 1/20 0.52
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 1/20 0.49
HTT P42858 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
HTR1A P08908 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10679736 0.76 RAB9A (0.92) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL14106331 0.75 RAB9A (0.62) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL5821824 0.75 RAB9A (0.62) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL733677 0.75 RAB9A (0.69) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL27320852 0.74 RAB9A (0.64) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL17396888 0.74 RAB9A (0.71) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL9033157 0.73 HTR2A (0.74) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL2825796 0.73 RAB9A (0.70) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL10159091 0.73 RAB9A (0.66) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL28709084 0.72 MAPT (0.61) RAB9ASMN1; SMN2MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2413696-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE Mount Sinai School Of Medicine Of New York University (US) 2012-02-08 EP claimed
WO-2010114636-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) 2010-10-07 WO claimed
EP-2413696-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE Mount Sinai School Of Medicine Of New York University (US) 2012-02-08 EP disclosed
WO-2010114636-A1 COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) 2010-10-07 WO disclosed